Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : Abt source : Www.biospace.com save search
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published: 2024-04-19 (Crawled : 15:00) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.4%
H: 3.01%
C: 2.94%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.75%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
first treatment for
Abbott Reports First-Quarter 2024 Results and Raises Midpoint of Full-Year Guidance Ranges
Published: 2024-04-17 (Crawled : 12:00) - biospace.com/
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.59%
H: 0.0%
C: 0.0%
results
Pelthos Therapeutics Establishes Board of Directors
Published: 2024-04-16 (Crawled : 15:00) - biospace.com/
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.29%
H: 0.0%
C: 0.0%
SVRA | $4.71 -2.08% -2.12% 680K
|
Health Technology
|
| O: -0.79%
H: 6.0%
C: 3.2%
INSM | $24.11 -0.86% -0.87% 2.3M
|
Health Technology
|
| O: 0.19%
H: 0.41%
C: -2.68%
therapeutics
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published: 2024-04-12 (Crawled : 14:30) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.13%
H: 0.0%
C: -2.94%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.65%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -1.06%
H: 0.21%
C: -1.05%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -3.02%
H: 0.0%
C: 0.0%
drug label astrazeneca expansion for kids
Former QuidelOrtho CEO Douglas Bryant Joins Board of Directors of Vital Biosciences
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 0.06%
H: 1.79%
C: 1.67%
ceo
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published: 2024-04-08 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.24%
H: 0.0%
C: -0.8%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.96%
H: 1.17%
C: 0.16%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.48%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 0.09%
H: 0.16%
C: -0.7%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.84%
H: 0.0%
C: 0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published: 2024-04-05 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.22%
H: 0.8%
C: 0.06%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.84%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.37%
H: 1.42%
C: 1.37%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
fda for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published: 2024-04-03 (Crawled : 13:30) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.29%
H: 1.34%
C: -0.64%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 0.11%
H: 0.37%
C: -0.77%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
fda drug schizophrenia
Abbott Receives FDA Approval for TriClip™, First-of-Its-Kind Device to Repair Leaky Tricuspid Heart Valve
Published: 2024-04-02 (Crawled : 15:30) - biospace.com/
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
fda device approval heart
AstraZeneca Kicks Off April With New PNH Approval
Published: 2024-04-02 (Crawled : 13:30) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -1.09%
H: 0.13%
C: -1.39%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.77%
H: 0.8%
C: 0.74%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.18%
H: 0.47%
C: 0.12%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -1.14%
H: 0.02%
C: -1.06%
approval astrazeneca
Abbott Receives FDA Clearance for Whole Blood Rapid Test to Help with Assessment of Concussion at the Patient's Bedside
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -1.38%
fda test rapid blood clearance
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published: 2024-03-29 (Crawled : 19:00) - biospace.com/
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
| Email alert
Add to watchlist
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
| Email alert
Add to watchlist
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
fda hepatitis kidney anemia
FDA Approves New Treatments for Two Rare Diseases
Published: 2024-03-27 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.26%
H: 0.0%
C: 0.0%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.84%
H: 1.48%
C: 1.29%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 1.48%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.06%
H: 0.0%
C: 0.0%
fda rare
Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published: 2024-03-25 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -100.0%
H: NaN%
C: Infinity%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.35%
H: 0.35%
C: -1.34%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.04%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.07%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
approved treatment
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published: 2024-03-22 (Crawled : 15:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published: 2024-03-22 (Crawled : 14:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.35%
H: 0.99%
C: -1.17%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.43%
H: 0.41%
C: -0.85%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 1.47%
H: 0.23%
C: -0.19%
fda hypertension
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published: 2024-03-21 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.0%
H: 1.6%
C: 0.89%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -0.03%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -0.56%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
fda drug iclusig hypertension
FDA Approves First Gene Therapy for Rare Pediatric Disease
Published: 2024-03-18 (Crawled : 23:00) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.33%
H: 0.13%
C: -1.51%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.2%
H: 0.08%
C: -1.14%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 1.71%
H: 0.36%
C: -2.52%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.81%
H: 0.0%
C: 0.0%
fda rare first disease therapy
Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published: 2024-03-15 (Crawled : 15:00) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: -0.62%
H: 0.59%
C: -1.01%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: -5.53%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
fda breyanzi week
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published: 2024-03-11 (Crawled : 17:00) - biospace.com/
PRGO | $30.06 -2.4% 0.0% 1.4M
|
Health Technology
|
| O: 0.0%
H: 2.38%
C: 1.12%
JNJ | News | $149.12 0.82% 0.3% 7.2M
|
Health Technology
|
| O: 0.43%
H: 0.0%
C: 0.0%
ABT | News | $107.07 -0.2% -0.09% 3.8M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
fda drug wegovy approved
Gainers vs Losers
| 74% | 26% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
Your saved searches
Save your searches and get alerts when important news are released.